(S)-5-((7-fluoro-6-methoxy-1-oxoisoindolin-2-yl)methyl)-5-(5-(3-oxopiperazin-1-yl)furo[3,2-b]pyridin-2-yl)imidazolidine-2,4-dione

ID: ALA4095929

PubChem CID: 46199503

Max Phase: Preclinical

Molecular Formula: C24H21FN6O6

Molecular Weight: 508.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1F)C(=O)N(C[C@@]1(c3cc4nc(N5CCNC(=O)C5)ccc4o3)NC(=O)NC1=O)C2

Standard InChI:  InChI=1S/C24H21FN6O6/c1-36-15-3-2-12-9-31(21(33)19(12)20(15)25)11-24(22(34)28-23(35)29-24)16-8-13-14(37-16)4-5-17(27-13)30-7-6-26-18(32)10-30/h2-5,8H,6-7,9-11H2,1H3,(H,26,32)(H2,28,29,34,35)/t24-/m0/s1

Standard InChI Key:  WSTMGDNKJKKYFC-DEOSSOPVSA-N

Molfile:  

     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
    9.3849  -16.1570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9766  -16.8737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8015  -16.8690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8972  -17.6614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7223  -17.6614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3098  -16.3903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6445  -16.8771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2181  -17.5813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8918  -18.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0442  -17.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5916  -17.0429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2204  -18.4663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5100  -18.8812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5150  -19.7021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2298  -20.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9409  -19.6891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9325  -18.8696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6597  -20.0944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6680  -20.9195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2079  -18.3285    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8597  -16.6224    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2043  -16.0614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0446  -15.4007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6489  -14.8431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3683  -15.2533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0810  -14.8353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0755  -14.0076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3514  -13.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6416  -14.0196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3426  -12.7743    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0553  -12.3592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0485  -11.5377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3313  -11.1288    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6194  -11.5478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6245  -12.3755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7603  -11.1202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6431  -18.4505    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  2  1  0
  4  5  1  0
  5  2  1  0
  2  6  1  0
  6  7  1  0
  7  4  1  0
  3  8  1  0
  8  9  1  0
  9 13  1  0
 12 10  1  0
 10  8  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 16 18  1  0
 18 19  1  0
  5 20  2  0
  7 21  2  0
  1 22  1  0
 22 25  1  0
 24 23  1  0
 23  1  2  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 28 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 32 36  2  0
 17 37  1  0
M  END

Associated Targets(Human)

ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.47Molecular Weight (Monoisotopic): 508.1507AlogP: 0.60#Rotatable Bonds: 5
Polar Surface Area: 146.11Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.63CX Basic pKa: 3.91CX LogP: 0.07CX LogD: 0.05
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.43Np Likeness Score: -0.82

References

1. Tong L, Kim SH, Rosner K, Yu W, Shankar BB, Chen L, Li D, Dai C, Girijavallabhan V, Popovici-Muller J, Yang L, Zhou G, Kosinski A, Siddiqui MA, Shih NY, Guo Z, Orth P, Chen S, Lundell D, Niu X, Umland S, Kozlowski JA..  (2017)  Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors.,  27  (14): [PMID:28558971] [10.1016/j.bmcl.2017.05.062]

Source